Mark Hillman Hillman Capital Management
Mark Hillman is associated with Hillman Capital Management, a firm focused on fundamental equity research and long-term portfolio management. The firm’s public filings are followed by investors interested in actively managed, research-driven U.S. equity exposure. Hillman’s process emphasizes business analysis and valuation discipline rather than short-term trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$9.77M |
| 2 |
T. Rowe Price
TROW
|
+$8.5M |
| 3 |
Adobe
ADBE
|
+$7.78M |
| 4 |
Salesforce
CRM
|
+$6.86M |
| 5 |
Biogen
BIIB
|
+$3.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$9.52M |
| 2 |
General Dynamics
GD
|
+$7.03M |
| 3 |
Lockheed Martin
LMT
|
+$2.44M |
| 4 |
RTX Corp
RTX
|
+$1.98M |
| 5 |
Wells Fargo
WFC
|
+$1.59M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.59% |
| 2 | Technology | 13.8% |
| 3 | Communication Services | 12.18% |
| 4 | Consumer Staples | 12.09% |
| 5 | Financials | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Kraft Heinz
KHC
$30.3B
| $10.7M | 3.39% |
271,223
+3,504
| +1% | +$131K |
|
2
GSK
GSK
$105B
| $10.3M | 3.26% |
188,551
+2,072
| +1% | +$113K |
|
|
K
3
DELISTED
Kellanova
K
| $10M | 3.18% |
165,487
+2,978
| +2% | +$179K |
|
4
Bristol-Myers Squibb
BMY
$137B
| $9.91M | 3.15% |
135,731
+1,794
| +1% | +$120K |
|
5
Amazon
AMZN
$2.79T
| $9.89M | 3.14% |
60,660
+1,000
| +2% | +$155K |
|
6
CVS Health
CVS
$119B
| $9.87M | 3.13% |
97,483
-11,615
| -11% | -$1.22M |
|
7
Microsoft
MSFT
$3.59T
| $9.81M | 3.12% |
31,834
+570
| +2% | +$171K |
|
|
8
ASML
ASML
$677B
| $9.74M | 3.09% |
+14,591
| New | +$9.77M |
|
9
Enterprise Products Partners
EPD
$82.1B
| $9.74M | 3.09% |
377,588
-40,202
| -10% | -$976K |
|
10
Simon Property Group
SPG
$70.6B
| $9.7M | 3.08% |
73,740
+652
| +0.9% | +$92.9K |
|
|
11
Wells Fargo
WFC
$254B
| $9.64M | 3.06% |
198,908
-29,638
| -13% | -$1.59M |
|
12
Compass Minerals
CMP
$1.09B
| $9.58M | 3.04% |
152,587
+12,830
| +9% | +$729K |
|
13
DuPont de Nemours
DD
$18.7B
| $9.41M | 2.99% |
101,870
+1,155
| +1% | +$113K |
|
14
AB InBev
BUD
$155B
| $9.34M | 2.97% |
155,584
+10,350
| +7% | +$638K |
|
15
Plains All American Pipeline
PAA
$17.4B
| $9.29M | 2.95% |
863,795
-162
| -0% | -$1.74K |
|
|
16
Biogen
BIIB
$32B
| $8.99M | 2.85% |
42,679
+15,488
| +57% | +$3.37M |
|
17
Boeing
BA
$169B
| $8.92M | 2.83% |
46,598
+2,363
| +5% | +$474K |
|
18
Intel
INTC
$476B
| $8.8M | 2.79% |
177,512
+11,534
| +7% | +$572K |
|
19
Alphabet (Google) Class A
GOOGL
$4.22T
| $8.41M | 2.67% |
60,480
+480
| +0.8% | +$65.2K |
|
|
20
T. Rowe Price
TROW
$23.8B
| $8.32M | 2.64% |
+55,026
| New | +$8.5M |
|
21
AT&T
T
$173B
| $8.25M | 2.62% |
462,443
+41,738
| +10% | +$772K |
|
22
Merck
MRK
$376B
| $8.16M | 2.59% |
99,499
+803
| +0.8% | +$63.3K |
|
23
Meta Platforms (Facebook)
META
$1.4T
| $7.64M | 2.43% |
34,377
+13,144
| +62% | +$3.29M |
|
24
Conagra Brands
CAG
$7.89B
| $7.44M | 2.36% |
221,717
+98,034
| +79% | +$3.34M |
|
|
MMP
25
DELISTED
Magellan Midstream Partners, L.P.
MMP
| $7.38M | 2.34% |
150,465
+1,338
| +0.9% | +$64.7K |
|
Similar funds
Mark Hillman's Q1 2022 Portfolio in Review
As of Q1 2022, Mark Hillman held 59 positions worth $315M, up 8.3% from $291M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Mark Hillman deployed $24.2M of net new capital in Q1 2022, opening 5 new positions and adding to 36 existing holdings. Its largest new stake was ASML: 14,591 shares worth $9.74M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was RTX Corp, an estimated $1.98M trimmed.
- Mark Hillman's largest Q1 2022 buy was ASML: 14,591 shares worth $9.74M.
- Mark Hillman added most to Salesforce in Q1 2022, an estimated $6.86M increase.
- Mark Hillman's biggest Q1 2022 reduction was RTX Corp, cutting an estimated $1.98M.
- Mark Hillman fully exited ExxonMobil in Q1 2022, selling an estimated $9.52M.
- Mark Hillman's ten largest holdings make up 32% of its $315M portfolio in Q1 2022.
- Mark Hillman opened 5 new positions and closed 11 in Q1 2022.
- Mark Hillman's portfolio value rose 8.3% quarter-over-quarter to $315M.
Based on Hillman Capital Management's 13F filing for Q1 2022, filed 16 May 2022.